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Purpose/Objective: Comparison of theoretical estimation of 
lethal DNA damage of normal mammalian cells during 
exposure to low-kV X-rays with an ex vivo assessment of 
double-strand strand breaks (DSBs) in tissue irradiated in 
vivo. 
Materials and Methods: 130 patients were treated with 
Intrabeam intraoperative radiotherapy of the tumour bed 
following breast cancer resection. Tissue samples were taken 
from the resection wall before and after irradiation with 50 
kV X-rays. Doses of 5 to 6 Gy were delivered at 1 cm from the 
edge of a treatment applicator. Time for dose delivery varied 
between 10 and 40 minutes. Tissue samples were sectioned 
and stained for phosphorylated γH2Ax, representative of DNA 
repair, to assess damage before and after irradiation. The 
proportion of stain was recorded on multiple slides spanning 
samples from 130 patients. Monte Carlo radiation transport 
calculations were used to determine the spectra of secondary 
electrons at the samples in situ. These spectra were used as 
input to a damage simulation code producing expected levels 
of damage. In combination with expected repair rates and 
irradiation times, theoretical estimates of DSBs remaining at 
the end of irradiation were made based on the linear-
quadratic model of radiation damage with repair. 
Results: Considerable variability was found in change in 
γH2Ax expression between pre and post-irradiation sections, 
though there is a trend for decreased accumulation with 
longer irradiation time, consistent with increased 
proportional repair. The theoretical results suggest a 
reduction in damage with increasing applicator size due to 
both increased beam hardening and longer irradiation times. 
There is however little similarity between theoretical and 
experimental determination of induced DSBs, with poor 
correlation as shown in the figure. 
 
 
Conclusions: Assessment of DNA damage occurring in humans 
is difficult and rare. We found poor correlation between 
theoretical DSB estimates and those made using ex vivo 
assessment of tissue samples. It is likely that insufficient 
time was available post irradiation for accumulation and 
equilibrium of γH2Ax. With potentially slow repair and a 
diversity of cell types present in sections, larger numbers of 
patients may allow differences in in vivo normal tissue repair 
with dose-rate to be distinguished above levels of noise and 
uncertainty in both the measurements and the model. 
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Purpose/Objective: Glioblastomas (GBM) are some highly 
lethal brain tumors despite a conventional treatment 
associating surgical resection and subsequent radio-
chemotherapy. Amongst these heterogeneous tumors, a 
subpopulation of chemo- and radioresistant GBM stem-like 
cells appears to be involved in the systematic GBM 
recurrence. Moreover, recent studies showed that 
differentiated tumor cells may have the ability to 
dedifferentiate and acquire a stem-like phenotype, a 
phenomenon also called plasticity, in response to 
microenvironment stresses such as hypoxia. We hypothesized 
that GBM cells could be subjected to a similar 
dedifferentiation process after ionizing radiations (IR), then 
supporting the GBM rapid recurrence after radiotherapy. 
Materials and Methods: In the present study we established 
several differentiated GBM cell lines isolated from patient 
resections and subjected them to a clinically relevant IR dose 
(3 Gy). We then characterized, after long term culture, the 
phenotypic and functional alterations displayed by these GBM 
cells using in vitro techniques (qPCR, western blot, flow 
cytometry, limiting dilution clonogenic assays) and in vivo 
experiments (orthotopically-xenografted nude mice). 
Results: We demonstrated that the exposure of 
differentiated GBM cells to a subtoxic IR dose potentiated the 
long-term reacquisition of stem-associated properties such as 
the ability to generate primary and secondary neurospheres, 
the expression of stemness markers and an increased 
tumorigenicity. We also identified during this process an up-
regulation of the anti-apoptotic protein survivin and we 
showed that its down-regulation by YM-155, a selective 
survivin inhibitor used in anti-cancer clinical trials, led to the 
blockade of the IR-induced plasticity.  
Conclusions: Altogether, these results demonstrated that 
irradiation could regulate GBM cell dedifferentiation via a 
survivin-dependent pathway. Targeting the mechanisms 
associated with IR-induced plasticity will likely contribute to 
develop some innovating pharmacological strategies for an 
improved radiosensitization of these aggressive brain 
cancers. 
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Purpose/Objective: To investigate the potential of ultrathin 
polyvinylpyrrolidone (PVP)-decorated tungsten oxide (W18O49) 
nanowires as an effective therapeutic platform for 
concurrent dose-enhancement radiation therapy (RT) and 
photothermal therapy (PT). 
Materials and Methods: W18O49 nanowires was synthesized 
using a modified solvothermal approach. The effects on 
photothermal conversion, production of singlet oxygen, and 
radiation dose enhancement in vitro were analyzed by 
aqueous solution heating, DPBF quenching, and MRI-mediated 
polymer gel dosimetry experiments. Mice harboring breast 
cancer cell line 4T1 xenografts were treated with RT/PT 
with/without administration of W18O49-PVP nanowires to 
evaluate their impact on treatment outcome. 
Results: The in vitro and in vivo experiments demonstrated 
that nanowires could generate extensive ablative/oxidative 
damages (i.e. heat / singlet oxygen) to cancer cells under the 
980 nm NIR-laser excitation and also serve as a radiation dose 
intensifier to achieve a locally enhanced X-ray dose 
deposition under radiotherapy. Tumor complete regression 
(CR) was observed in the animals receiving concurrent 
W18O49-based RT/PT therapies and no recurrence was found 
in the 9-month follow-up period. Moreover, high atom 
number (Z = 74) and strong X-ray attenuation ability of 
tungsten element (4.438 cm2/g, 100 KeV) enabled these 
nanowires as excellent CT contrast agents for image-guided 
therapy. The toxicity study demonstrated tolerable toxic 
profile with minor side effects on hematological system and 
major organs of mice within one month.  
Conclusions: This study showed promising roles of W18O49-PVP 
nanowires in radiation therapy and photothermal therapy 
with potential image guidance capability as CT contrast 
agents.  
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Purpose/Objective: In this review we assess the current 
clinical experience regarding the abscopal effect of RT and 
try to identify the potential of immune therapy in this 
context. 
Materials and Methods: We identified papers through 
searches of Medline and Embase with the search term 
'abscopal' from 1960 until July, 2014. The following inclusion 
criteria were used: patients had to receive single or multiple 
fractions of radiotherapy for any malignancy. Following 
radiotherapy, a non-irradiated tumor site needed to show 
regression. Whole body irradiation or concurrent systemic 
treatments with a cytotoxic drug were not allowed. 
Sequential cytotoxic treatment after radiotherapy was not 
allowed unless an abscopal radiotherapy response was 
assessed before the following systemic treatment was given. 
Concurrent or sequential immune modifying therapy was 
included. 
Results: Thirty case reports were found, all based on one or 
more clinical cases. Two case reports which described 12 
individual clinical cases were rejected due to insufficient 
clinical information. Ultimately, we retrieved 23 case reports 
of a perceived abscopal effect through radiation therapy with 
or without immune therapy. Patient age ranged from 28 to 83 
years, with a median age of 64,5. Interestingly, renal cell 
carcinoma was the most frequent histology, with 7 cases, 
followed by 4 cases of hepatocellular carcinoma. Radiation 
doses varied as well, with a median total dose of 30 Gy 
(range 12 Gy – 60,75 Gy). Fractionation size ranged from 1,2 
Gy to 26 Gy. Eight cases were irradiated on the primary 
tumor site, 14 on a distant metastatic or nodal site. Time to 
documented abscopal response ranged between less than 1 
and 24 months, with a median reported time of 5 months. 
Once an abscopal response was achieved, a median time of 
13 months went by before disease progression occurred or 
the reported follow-up ended (range 3-39 months).  
 
 
Conclusions: Abscopal effects were observed at all ages, 
with a trend towards immunogenic tumor types and with 
substantial differences in radiotherapy regimens and 
techniques. At the same time, the rarity of documented 
reports suggest that abscopal effects induced by RT alone are 
